Abiopharma

Clinical trial NCT03924817 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2025-06-30 → 2026-12-31 3. primary completion date: 2025-05-31 → 2026-10-31

Clinical trial NCT05701488 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06795022 updates: 1. completion date: 2028-07-25 → 2028-06-30 2. primary completion date: 2028-02-25 → 2027-06-30

Clinical trial NCT06021054: start date: 2023-11-14 → 2023-11-01.

Clinical trial NCT06162195 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2024-09-01 → 2026-07-21 3. completion date: 2035-04-01 → 2036-12-31 4. primary completion date: 2027-04-01 → 2028-12-31

Clinical trial NCT06397989 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-07-31 3. enrollment: 5800 → 5731 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06576050 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2024-11-01 → 2025-08-02

Clinical trial NCT06092970 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-06-30 → 2026-02-06 3. primary completion date: 2026-06-30 → 2026-02-06 4. enrollment: 379 → 353 participants

Clinical trial NCT05450744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-06-01 3. primary completion date: 2026-06-01 → 2027-06-01

Clinical trial NCT06384352: intervention model: SINGLE_GROUP → PARALLEL.